Application of molecular imaging to address current clinical challenges in breast cancer
Breast cancer has multiple sub-types, designated in clinical practice by the presence or absence of prognostic and predictive biomarkers: oestrogen receptor, progesterone receptor and the human epidermal growth receptor 2 (HER2). Molecular imaging offers the opportunity firstly to non-invasively and...
Main Author: | Glendenning, Jennifer Louise |
---|---|
Published: |
King's College London (University of London)
2017
|
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.733375 |
Similar Items
-
Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge
by: Grace G. Bushnell, et al.
Published: (2021-05-01) -
SPECT/CT imaging in breast cancer - current status and challenges
by: Milan Simanek, et al.
Published: (2016-12-01) -
Molecular Capsule Catalysis: Ready to Address Current Challenges in Synthetic Organic Chemistry?
by: Ivana Nemethova, et al.
Published: (2020-08-01) -
Molecular cytogenetics of breast cancer : clinical perspectives
by: Loveday, Ruth Louise
Published: (1999) -
Addressing challenges of molecular precision diagnostics for cancer patients in the genomics era
by: Robbe, Pauline
Published: (2017)